한국어 English

News & Notice

Thank you for visiting PROTOX’s website

MFDS(KOREA), approved Protox for Export Authorization of Protoxin.

14 August 2020

▶ News Article


Protox, Clinical trial Phase 1 Plan(IND) approval and GMP
 permission acquisition

03 August 2020

▶ News Article


PROTOX submits the application of botulinum toxin clinical trial

27 April 2022

▶ News Article


96, Jeyakgongdan 4-gil, Sangsin-ri, Hyangnam-eup, Hwaseong-si, Gyeonggi-do  |  TEL. 1522-4140  |  FAX. +82-2-572-9011

COPYRIGHT © 2019 Protox. All rights reserved